Buscar en
Nursing
Toda la web
Inicio Nursing ¿Consume su paciente “sales de baño”?
Información de la revista
Vol. 30. Núm. 4.
Páginas 20-25 (Abril 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. 4.
Páginas 20-25 (Abril 2012)
Acceso a texto completo
¿Consume su paciente “sales de baño”?
Visitas
1468
Mark M. McGraw
Trabaja como enfermero en el servicio de urgencias y en cuidados intensivos y cuidados críticos en el Christiana Care Health System en Wilmington (Delaware)
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.T. Melton.
Bath salts: an “Ivory Wave” epidemic?, (2011),
[2.]
New Jersey Office of the Attorney General. Designer drugs labeled as “bath salts”: facts about synthetic cathinones. 2011. http://www.nj.gov/oag/ca/bathsalts/SyntheticCathinonesFacts.pdf.
[3.]
P.V. Kavanagh, S. McNamara, D. Angelov, S. McDermott, D. Mullan, S.A. Ryder.
The characterization of ‘legal highs’ available from head shops in Dublin (Poster).
The National Drug Advisory and Drug Treatment Board, (2010),
[4.]
U.S. Drug Enforcement Administration. Chemicals used in “bath salts” now under federal control and regulation. 2011. http://www.justice.gov/dea/pubs/pressrel/pr102111.html.
[5.]
National Institute on Drug Abuse. NIDA Info-Facts: Hallucinogens—LSD, peyote, psilocybin, and PCP. http://www.drugabuse.gov/infofacts/hallucinogens.html.
[6.]
U.S. Department of Justice. Drug Enforcement Administration. Office of Diversion Control. Controlled Substance Schedule. 2011. http://www.deadiversion.usdoj.gov/schedules/index.html.
[7.]
P.I. Dargan, S. Albert, D.M. Wood.
Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.
QJM., 103 (2010), pp. 875-879
[8.]
D.M. Wood, S.L. Greene, P.I. Dargan.
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
Emerg Med J., 28 (2010), pp. 280-282
[9.]
T.M. Brunt, A. Poortman, R.J. Niesink, W. van den Brink.
Instability of the ecstasy market and a new kid on the block: mephedrone.
[10.]
M. Farrell.
New drugs. Presentation.
European Monitoring Centre for Drugs and Drug Addiction, (2010),
[11.]
American Association of Poison Control Centers. Bath salts data. 2011. http://www.aapcc.org/dnn/Portals/0/8.02.2011Bath%20Salts%20Data%20for%20Website.pdf.
[13.]
The Vaults of Erowid. Psychoactive vault. 2011.http://erowid.org/psychoactives/psychoactives.shtml.
[14.]
Delaware Health Alert Network. Designer drug “bath salts” use in Delaware. 2011. Delaware Health Alert #257. http://dhss.delaware.gov/dhss/dph/php/alerts/dhan257.html.
[15.]
F. Schifano, A. Albanese, S. Fergus, et al.
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues.
Psychopharmacology (Berl)., 214 (2011), pp. 593-602
[16.]
D. James, R.D. Adams, R. Spears, et al.
Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service.
Emerg Med J., 28 (2011), pp. 686-689
[17.]
H.S. Kim, A. Aftab, M. Shah, J. Nayar.
Physical and psychological effects of the new legal high ‘Ivory Wave’: a case report.
Br J Med Practitioners, 3 (2010), pp. 44-46
[18.]
A. Winstock, L. Mitcheson, J. Ramsey, S. Davies, M. Puchnarewicz, J. Marsden.
Mephedrone: use, subjective effects and health risks.
Addiction., 106 (2011), pp. 1991-1996
[19.]
A.R. Winstock, J. Marsden, L. Mitcheson.
What should be done about mephedrone?.
BMJ., 340 (2010), pp. c1605
[20.]
K.M. Babu, E.W. Boyer.
Emergency department evaluation of acute onset psychosis in children., (2011),
[21.]
C.C. Hoecker.
Designer drugs of abuse in children and adolescents., (2011),
[22.]
J. McCord, H. Jneid, J.E. Hollander, et al.
Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.
[23.]
S. Fröhlich, E. Lambe, J. O’Dea.
Acute liver failure following recreational use of psychotropic “head shop” compounds.
Ir J Med Sci., 180 (2011), pp. 263-264
[24.]
G. Moore, J.A. Pfaff.
Assessment and management of the acutely agitated or violent adult., (2011),
[25.]
E.D. Katz.
Combative, convulsing and crazy: care of the altered and agitated patient.
Presentation at the Boston Scientific Assembly,
[26.]
G. Garrett, M. Sweeney.
The serotonin syndrome as a result of mephedrone toxicity.
[27.]
M.D. Jibson.
[28.]
Bath salts blamed for deaths, crimes. Houston, TX: KPRC Local 2; March 21, 2011. http://www.click2houston.com/news/27268930/detail.html.
[29.]
More local deaths, injuries from bath salts.Dayton, OH: WHIOTV.COM; July 25, 2011.http://www.whiotv.com/news/28660869/detail.html.
[30.]
T. Craig.
Galveston dad wants ‘bath salts’ banned after son's death.
[31.]
I. Morales.
Tampa man is first reported death in Florida from ingesting ‘bath salt’ drug.
Copyright © 2012. Lippincott Williams & Wilkins
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos